agenda – october 17, 2012 - delaware · 5.1.7 hiren shah 5.1.8 larry shuster 5.1.9 chimaobi...

PPoosstteedd:: 1100//1166//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – September 19, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-29-08 – Closed 13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Assigned 13-13-11 – Assigned 13-14-11 – Forwarded to Office of Attorney General 13-15-11 – Assigned 13-17-11 – Closed 13-18-11 – Closed 13-19-11 – Forwarded to Office of Attorney General 13-20-11 – Closed 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 4.2 Regulation 17 and 3.1.2.7 Update*

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, October 17, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – October 17, 2012

5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Waheed Aziz 5.1.2 Elizabeth Baker 5.1.3 Umsa Uppal 5.1.4 Adje Koffi 5.1.5 Jaime McGee 5.1.6 Alexander Kashmanian 5.1.7 Hiren Shah 5.1.8 Larry Shuster 5.1.9 Chimaobi Odumuko 5.1.10 David Pouchan 5.1.11 Nkechi Anako* 5.1.12 Valerie Duffy* 5.1.13 Salma Habeeb* 5.2 Pharmacist Intern Approval Ratification

5.2.1 Dylan Howery 5.2.2 Namrata Chapla 5.3 Facility Licensure Approval Ratifications

5.3.1 Non–Resident Pharmacies

5.3.1.1 Century Pharmacy LLC 5.3.1.2 Transdermal Therapeutics, Inc. 5.3.1.3 Weatherford Compounding Pharmacy, LLC 5.3.1.4 Liberty Medical Supply Inc. 5.3.2 Wholesale Distributors

5.3.2.1 The Compounding Center Inc. 5.3.2.2 Midwest Veterinary Supply, Inc. (PA) 5.3.2.3 Midwest Veterinary Supply, Inc. (WI) 5.3.2.4 Community Durable Medical Equipment Co. Inc. 5.3.2.5 Accredo Health Group, Inc. 5.3.2.6 Perrigo Pharmaceuticals Co. 5.3.2.7 Family Enterprises, LLC 5.3.2.8 Cardinal Health* 5.3.2.9 Associated Pharmacies dba API* 5.3.2.10 EMD Millipore Corporation* 5.3.2.11 Southern Anesthesia & Surgical, Inc.* 5.3.3 Medical Gas Dispensers

5.3.3.1 Community Surgical Supply of Toms River, Inc. 5.3.3.2 Lincare Inc. 5.3.4 Retail Pharmacies

5.3.4.1 Care Community Pharmacy dba Care Health Mart Pharmacy 5.3.4.2 Biotek Remedys 5.3.4.3 Delaware CVS Pharmacy, LLC dba CVS Pharmacy 3038


5.4 Pharmacist-In-Charge Interview

5.4.1 Mohammad Farooqi 5.4.2 Paresh Nakrani 5.4.3 Walter Scott* 5.4.4 John Williams, Jr.*

5.5 Presentation on Hospice and Palliative Care – Sheila Grant 5.6 Legislative Memo from James Collins 6.0 Committee Reports

6.1 Joint Practice – Kim Robbins 6.2 Physician’s Assistant – Sebastian Hamilton 6.3 Newsletter – Sandy Robinson, Joli Martini and David Dryden 6.4 Legislative – Sandy Robinson, Geoffrey Christ, Sebastian Hamilton, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.5 Continuing Education – Sandy Robinson, Joli Martini and Geoffrey Christ 6.6 Consumer Affairs – Matt Maher, Ron Sherman and Jay Galloway 6.7 Professional Liaison – Sandy Robinson and Joli Martini 6.8 MPJE Study – Sebastian Hamilton, David Dryden and Alicia Kluger

6.9 Controlled Substance Liaison – Geoffrey Christ, Howard Simon, Jay Galloway and David Dryden

6.10 USP 795 & 797 – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic and

Cheryl Peterson 7.0 Board Correspondence 8.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 9.0 Other Business before the Board (for discussion only) 10.0 Public Comments 11.0 Next Meeting – November 21, 2012 12.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.


Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL [email protected]

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.